373 related articles for article (PubMed ID: 14532971)
1. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma.
Leung WK; To KF; Go MY; Chan KK; Chan FK; Ng EK; Chung SC; Sung JJ
Int J Oncol; 2003 Nov; 23(5):1317-22. PubMed ID: 14532971
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 pathway correlates with vascular endothelial growth factor expression and tumor angiogenesis in hepatitis B virus-associated hepatocellular carcinoma.
Cheng AS; Chan HL; To KF; Leung WK; Chan KK; Liew CT; Sung JJ
Int J Oncol; 2004 Apr; 24(4):853-60. PubMed ID: 15010822
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
[TBL] [Abstract][Full Text] [Related]
4. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer.
Gong W; Wang L; Yao JC; Ajani JA; Wei D; Aldape KD; Xie K; Sawaya R; Huang S
Clin Cancer Res; 2005 Feb; 11(4):1386-93. PubMed ID: 15746037
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer.
Koga T; Shibahara K; Kabashima A; Sumiyoshi Y; Kimura Y; Takahashi I; Kakeji Y; Maehara Y
Hepatogastroenterology; 2004; 51(60):1626-30. PubMed ID: 15532792
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
[TBL] [Abstract][Full Text] [Related]
7. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ
Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of COX-2, vascular endothelial growth factor and microvessel density in human renal cell carcinomas.
Hemmerlein B; Galuschka L; Putzer N; Zischkau S; Heuser M
Histopathology; 2004 Dec; 45(6):603-11. PubMed ID: 15569051
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma.
von Rahden BH; Stein HJ; Pühringer F; Koch I; Langer R; Piontek G; Siewert JR; Höfler H; Sarbia M
Cancer Res; 2005 Jun; 65(12):5038-44. PubMed ID: 15958546
[TBL] [Abstract][Full Text] [Related]
11. [The potential role of Id1 in COX-2 mediated angiogenesis in gastric cancer].
Lei T; Han S; Guo XY; Ding R; Li Y; Xie HH; Bai FH; Wu KC; Ding J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1570-5. PubMed ID: 17785115
[TBL] [Abstract][Full Text] [Related]
12. Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma.
Lim SC; Park SY; Do NY
Oncol Rep; 2003; 10(5):1073-9. PubMed ID: 12883661
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.
Marrogi AJ; Travis WD; Welsh JA; Khan MA; Rahim H; Tazelaar H; Pairolero P; Trastek V; Jett J; Caporaso NE; Liotta LA; Harris CC
Clin Cancer Res; 2000 Dec; 6(12):4739-44. PubMed ID: 11156228
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer.
Uefuji K; Ichikura T; Mochizuki H
Clin Cancer Res; 2000 Jan; 6(1):135-8. PubMed ID: 10656441
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression.
Kawabe A; Shimada Y; Uchida S; Maeda M; Yamasaki S; Kato M; Hashimoto Y; Ohshio G; Matsumoto M; Imamura M
J Surg Oncol; 2002 Jun; 80(2):79-88. PubMed ID: 12173384
[TBL] [Abstract][Full Text] [Related]
16. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.
Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
Oncol Rep; 2004 Feb; 11(2):309-13. PubMed ID: 14719060
[TBL] [Abstract][Full Text] [Related]
17. COX-2 correlates with F-box protein, Skp2 expression and prognosis in human gastric carcinoma.
Honjo S; Kase S; Osaki M; Ardyanto TD; Kaibara N; Ito H
Int J Oncol; 2005 Feb; 26(2):353-60. PubMed ID: 15645119
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia up-regulates the effects of prostaglandin E2 on tumor angiogenesis in ovarian cancer cells.
Zhu G; Saed GM; Deppe G; Diamond MP; Munkarah AR
Gynecol Oncol; 2004 Aug; 94(2):422-6. PubMed ID: 15297183
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts.
Miura S; Tatsuguchi A; Wada K; Takeyama H; Shinji Y; Hiratsuka T; Futagami S; Miyake K; Gudis K; Mizokami Y; Matsuoka T; Sakamoto C
Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G444-51. PubMed ID: 15246970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
